NR4A1 and breast cancer: HER2+-enriched BC (ER(−) PR(−) HER2+, Ki 67(high)) subtype is negative for hormone receptors ER and/or PR, respectively, but positive for human epidermal growth factor receptor type 2 (HER2+), and Ki67 index rates are high.